Structure Therapeutics Inc - ADR
XNAS:GPCR
| Market Cap (Intraday) | 3.31B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $54.35 |
| 50-Day MA | $71.72 |
| 200-Day MA | $40.54 |
Structure Therapeutics Inc - ADR Stock, XNAS:GPCR
601 Gateway Boulevard, Suite 900, South San Francisco, California 94080
United States of America
Phone: +1.650.457.1978
Number of Employees: 163
Description
Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. The company was founded by Raymond Stevens in February 2019 and is headquartered in South San Francisco, CA.